Exicure Inc (DE:2H0)
FRANKFURT:2H0
Holding DE:2H0?
Track your performance easily

Exicure (2H0) Stock Price & Analysis

1 Followers

2H0 Stock Chart & Stats


Financials

Annual

2H0 FAQ

What was Exicure Inc’s price range in the past 12 months?
Exicure Inc lowest stock price was €1.30 and its highest was €4.22 in the past 12 months.
    What is Exicure Inc’s market cap?
    Currently, no data Available
    When is Exicure Inc’s upcoming earnings report date?
    Exicure Inc’s upcoming earnings report date is Mar 06, 2025 which is in 166 days.
      How were Exicure Inc’s earnings last quarter?
      Exicure Inc released its earnings results on Aug 13, 2024. The company reported -€0.313 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.313.
        Is Exicure Inc overvalued?
        According to Wall Street analysts Exicure Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Exicure Inc pay dividends?
          Exicure Inc does not currently pay dividends.
          What is Exicure Inc’s EPS estimate?
          Exicure Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Exicure Inc have?
          Exicure Inc has 1,730,241 shares outstanding.
            What happened to Exicure Inc’s price movement after its last earnings report?
            Exicure Inc reported an EPS of -€0.313 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.715%.
              Which hedge fund is a major shareholder of Exicure Inc?
              Among the largest hedge funds holding Exicure Inc’s share is Carlson Capital LP. It holds Exicure Inc’s shares valued at N/A.
                ---

                Exicure Stock Smart Score

                Company Description

                Exicure Inc

                Exicure, Inc. engages in the provision of clinical stage biotechnology company. It offers 3-dimensional, spherical nucleic acid architecture unlocks the potential of nucleic acid therapeutics. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Exicure
                Abeona Therapeutics
                Cyclacel Pharmaceuticals
                Eloxx Pharmaceuticals
                Aldeyra Therapeutics
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis